ABSTRACT
Most of the clinical and microscopic characteristics of congenital and hereditary hair shaft abnormalities were well described many years ago. Because of this and because many of these conditions have obvious pedigrees, the targeted topical selective gene therapy being developed for hair follicle faults is feasible. Impressive progress has been made in our knowledge of genes that control normal development and anomalies and the search is on to define these genes in hair diseases.
